Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients

Launched by POWER LIFE SCIENCES INC. · Oct 20, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how patients with treatment resistant depression engage with new treatments. Treatment resistant depression is a type of depression that doesn’t respond well to standard treatments. The trial aims to see if new medications are more effective than existing ones by looking closely at how many participants complete the study and how many choose to leave the study early.

To be eligible for this trial, you must be at least 18 years old, have a diagnosis of treatment resistant depression, and be able to give written consent to participate. Importantly, you should not have received any previous treatment for this condition. If you join the trial, you can expect to be part of a study that will help researchers gather information to better understand treatment options for depression, which could ultimately benefit others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of treatment resistant depression
• • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
• • No prior treatment for treatment resistant depression
• Exclusion Criteria:
• • Enrolled in another research study
• • Inability to provide written informed consent
• • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial